Category Added in a WPeMatico Campaign
In early clinical results, Sarepta’s αvβ6 integrin-targeted siRNA approach achieves high muscle concentrations without dose limiting toxicity for FSHD1 and…
Read More »FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission 30-patient pivotal study initiated, evaluating…
Read More »Board to evaluate a range of alternatives while continuing to support core business priorities ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #MASLD—ENDRA Life…
Read More »BEIJING, March 25, 2026 /PRNewswire/ — Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC and HKEX: 3896),…
Read More »STOCKHOLM, March 25, 2026 /PRNewswire/ — Einride AB (“Einride” or the “Company”), a technology company driving the transition to cost-efficient electric…
Read More »Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that…
Read More »Advances Scalable U.S. Drone and Additive Manufacturing Capabilities Aligned with Growing Defense and Counter-UAS Demand DENVER–(BUSINESS WIRE)–$BURU #NYSE–NUBURU, Inc. (NYSE…
Read More »
New York, March 25, 2026 /PRNewswire/ — Following the success of the Saramonic Air microphone, Saramonic announced the Saramonic Air…
Read More »Earnings Call Scheduled for 8:00 a.m. ET on March 27, 2026 SINGAPORE, March 25, 2026 /PRNewswire/ — 51Talk Online Education…
Read More »DENVER–(BUSINESS WIRE)–Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced that it proposes to offer $450.0 million aggregate principal amount of…
Read More »